NEURIMMUNE HOLDING
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with high unmet medical needs. With its unique Reverse Translational Medicine™ platform, Neurimmune creates recombinant human-derived monoclonal antibodies with biophysical characteristics closely resembling those occurring in healthy elderly. These antibodies display unique properties such as target selectivity, superior pharmacodynamics and low imm... unogenicity, resulting in superior risk profiles and excellent efficacy. Neurimmune’s pipeline comprises programs for a broad variety of disease related targets and specific target conformations. These include misfolded, oligomeric, fibrillar or post-translationally modified forms of disease-associated proteins as well as physiological conformations involved in major disease pathways.
NEURIMMUNE HOLDING
Industry:
Biotechnology Information Technology Pharmaceutical
Founded:
2006-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.neurimmune.com
Total Employee:
51+
Status:
Active
Contact:
41 44 755 46 46
Email Addresses:
[email protected]
Total Funding:
150 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Domain Not Resolving Mobile Non Scaleable Content
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
BioSilta
BioSilta Ltd, a developer of advanced microbial growth systems,
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
PBS Biotech
PBS Biotech is produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Sutro Biopharma
Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Biogen Idec
Biogen Idec investment in Venture Round - Neurimmune Holding
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-03-04 | NovaGo Therapeutics | Neurimmune Holding investment in Series A - NovaGo Therapeutics | 10 M CHF |
| 2016-12-08 | AL-S Pharma | Neurimmune Holding investment in Seed Round - AL-S Pharma | N/A |
Official Site Inspections
http://www.neurimmune.com Semrush global rank: 1.06 M Semrush visits lastest month: 31.62 K
- Host name: cloudone.goldinteractive.ch
- IP address: 46.231.204.136
- Location: Lengnau Switzerland
- Latitude: 47.1838
- Longitude: 7.3737
- Timezone: Europe/Zurich
- Postal: 2543
